Labeling for nicotine replacement products should direct physician consult, expert suggests.
This article was originally published in The Tan Sheet
Executive Summary
SMOKING CESSATION PRODUCT LABEL PHYSICIAN CONSULTATION DIRECTION necessary if the product is "not doing what it is supposed to do" as part of materials available to consumers, David Sachs, MD, Palo Alto Center for Pulmonary Disease Prevention, suggested at a June 9 meeting of FDA's Drug Abuse Advisory Committee in Bethesda, Md. Sachs addressed the committee during the open public hearing, saying nicotine replacement product labeling for consumers "must clearly...state, as is done for each and every other OTC category...when patients should see a physician because the medication is not doing what it is supposed to do."